A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer
NCT01152437
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class
Conditions
Colorectal Neoplasms
Interventions
DRUG:
BIBW 2992
DRUG:
Cetuximab
Sponsor
Boehringer Ingelheim